Traceability, a Familiar Friend

Modern digital technologies can build in traceability from development to commercialization to optimize outcomes. As cell and gene therapy makes inroads in the life sciences marketplace, an important existing concept from this space has begun to draw more attention than it had previously: traceability.

Emerson’s Director of Life Sciences Strategy Michalle Adkins and Bob Lenich, business director of Emerson’s industrial software business share their thoughts in this article in Pharma Manufacturing magazine on traceability to ensure product efficacy.
 

Latest News

Emerson’s New Ovation 4.0 to Deliver Software-Defined, AI-Ready Automation Platform for Power and...

New automation architecture accelerates plant modernization with a more flexible and user-centric approach

Emerson Celebrates 150 Years of Crosby Overpressure Protection and Valve Innovation

Crosby pressure relief valves improve safety and increase uptime by delivering reliable overpressure protection across a wide range of critical...

Emerson Partners with MSTelcom

MSTelcom has chosen Emerson to provide the company’s full automation portfolio for energy and industrial customers in Angola, further advancing...
Please enable JavaScript to use this website.